Skip to main content

Table 4 Results of the Mixed model ANOVAs for effects of protocol (SMA vs DLPFC rTMS) and time (pre-intervention, post-intervention) on OCD, anxiety and depressive symptoms in pharmacoresistant OCD patients

From: Efficacy and clinical predictors of response to rTMS treatment in pharmacoresistant obsessive-compulsive disorder (OCD): a retrospective study

Measure

Source

df

Mean square

F

p-value

partial eta2

Y-BOCS

Time

1,63

958.15

53.51

0.001

0.46

Protocol

1,63

132.82

1.70

0.197

0.01

Time*protocol

1,63

1.15

0.06

0.803

0.05

BAI

Time

1,63

2727.96

34.90

0.001

0.36

Protocol

1,63

58.06

0.43

0.511

0.18

Time*protocol

1,63

73.49

0.94

0.336

0.01

BDI-II

Time

1,63

1044.46

19.97

0.001

0.24

Protocol

1,63

119.65

1.01

0.318

0.02

Time*protocol

1,63

0.004

0.01

0.993

0.01

  1. Y-BOCS Yale-Brown Obsessive-Compulsive Scale, BAI Beck Anxiety Inventory, BDI-II Beck Depression Inventory. Significant results are highlighted (p ≤ 0.05) in bold